Invited Speakers SASAT 2008


  1. A. Nicolaides (Cyprus) - IUA Consensus on DVT and LMWHs
  2. R. Kennedy (USA) - Generic Equivalence Today
  3. R. Hull (Canada) - Clinical Differentiation of LMWHs
  4. W. Leong (Canada) - ACCP - s Position
  5. W. Haque (Canada) - Bioequivalence of Complex Drugs
  6. G. Rao (USA) - Generic Antithrombotic Drugs in India
  7. J. Fareed (USA) - Are Current Guidelines Valid?
  8. R. Wahi (USA) - A Clinicians Perspective
  9. W. Raake (Germany) - EMEA and USFDAs Position
  10. F. Ofosu (Canada) - Issues on Heparins
  11. E. Ramacciotti (Brazil/USA) - Immunogenic Inequivalence
  12. R. Saxena (India) - HIT and Generic LMWHs
  13. E. Kalodiki (UK) - IUA Whitepaper
  14. B. K. Rao (India) - Cost Factors
  15. O. Iqbal (USA) - Anticoagulant Effects of Generic LMWHs
  16. J. Harenberg (Germany) - Report of the ADHOC Group of the ISTH
  17. M. Ahluwalia (USA) - Contaminants in Heparins
  18. V. Arora (India) - A surgeons perspective
  19. D. Van Thiel (USA) - Safety issues
  20. L. Pathak (India) - Cardiovascular implications
  21. P. Aggarwal (USA) - FDA compliance issues
Additional topics will be included in the final program. This Summit will also discuss the white paper based on the 2007-2008 Summit.

 

Conference Scope - Scientific Program - Invited Speakers - Awards & Arrangements